Author/Authors :
MU, Min Department of Medical Frontier Experimental Center - School of Medicine - Anhui University of Science and Technology - Anhui, China , WU, Jing Department of Medical Frontier Experimental Center - School of Medicine - Anhui University of Science and Technology - Anhui, China , WANG, Jian-Hua Department of Medical Frontier Experimental Center - School of Medicine - Anhui University of Science and Technology - Anhui, China , TAO, Xin-Rong Department of Medical Frontier Experimental Center - School of Medicine - Anhui University of Science and Technology - Anhui, China , HU, Dong Department of Medical Frontier Experimental Center - School of Medicine - Anhui University of Science and Technology - Anhui, China , LIU, Kai Department of Medical Frontier Experimental Center - School of Medicine - Anhui University of Science and Technology - Anhui, China , FANG, Ke-Hong Department of Medical Frontier Experimental Center - School of Medicine - Anhui University of Science and Technology - Anhui, China , XUE, Song Department of Medical Frontier Experimental Center - School of Medicine - Anhui University of Science and Technology - Anhui, China , SHANG, Jie Department of Medical Frontier Experimental Center - School of Medicine - Anhui University of Science and Technology - Anhui, China
Abstract :
Tuberculosis has still been identified as a serious public health problem in the world and the single infectious diseases causing the largest number of deaths . According to WHO, global TB con-trol in 2009 annual report, 13.7 million people fell ill with TB, 9.27 million became new cases and 1.77 million died from the disease per year .
Keywords :
Mellitus , WHO , global TB , multi-drug
